Cargando…
Personalized Evaluation of Biomarker Value: A Cost-Benefit Perspective
For a patient who is facing a treatment decision, the added value of information provided by a biomarker depends on the individual patient’s expected response to treatment with and without the biomarker, as well as his/her tolerance of disease and treatment harm. However, individualized estimators o...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938856/ https://www.ncbi.nlm.nih.gov/pubmed/27446505 http://dx.doi.org/10.1007/s12561-014-9122-4 |